Jefferies 2019 Global Healthcare Conference
AGENDA
JUNE 4-7, 2019
Grand Hyatt New York, NY
Jefferies 2019 Global Healthcare Conference
You are invited to attend the Jefferies 2019 Global Healthcare Conference taking place June 4-7 at the Grand Hyatt in New York City.
Following the success of our 2018 conference, with over 400 participating companies and 2,700 attendees, we will again feature an extensive range of public & private healthcare companies across the Biopharmaceuticals, Life Sciences, Healthcare Services, Healthcare IT and Medical Technology sectors. This global gathering of leading executives, institutional investors, private equity investors and VCs will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally.
The four-day conference will be comprised of company presentations, Q&A breakout sessions, keynotes & thematic panels. Company management teams and investors will also have the opportunity to participate in 1x1 and small group meetings.
To add this conference to your Microsoft Outlook calendar, click here.
REGISTRATION: Please contact your Jefferies representative
PARTICIPATING COMPANIES: 060419
HOTEL INFORMATION: Jefferies has reserved a block of rooms at the Grand Hyatt New York (109 E. 42nd Street at Grand Central Terminal) at a negotiated rate of $445 per night (plus tax). Rooms are based on availability and reservations must be made by Monday, May 13 in order to guarantee the conference rate. Please note that rooms must be cancelled by 3pm EST at least 72 hours prior to arrival. To make a reservation, please click here. For any questions, you can call the hotel directly at 1-800-233-1234.
QUESTIONS: healthcareconference@
? 2019 Jefferies LLC. Member SIPC.
AGENDA TUESDAY, JUNE 4, 2019
Jefferies 2019 Global Healthcare Conference
7:30 AM 8:00 AM 8:30 AM
9:00 AM 9:30 AM 10:00 AM 10:30 AM 11:00 AM
11:30 AM
BALLROOM 1 BREAKOUT: URIS
Breakfast & Registration
BALLROOM 2 BREAKOUT: JUILLIARD
BALLROOM 3 BREAKOUT: BROADWAY
BALLROOM 4 BREAKOUT: CARNEGIE
BALLROOM 5 BREAKOUT: ALVIN
MOROSCO BREAKOUT: PLYMOUTH
IMPERIAL BREAKOUT: BOOTH
Albireo Pharma, Inc. (ALBO) Biotechnology Ron Cooper, President & CEO
Ultragenyx Pharmaceutical Inc. (RARE) FC Biotechnology Shalini Sharp, CFO
Sartorius AG (SARTF)** MedTech Rainer Lehmann, CFO; Ben Orzelek, Head of IR
Twist Bioscience Corporation Menlo Therapeutics Inc.
(TWST)
(MNLO)
Life Sciences
Biotechnology
Emily Leproust, CEO
Steve Basta, CEO
ImmunityBio, Inc. (Private) Telix Pharmaceuticals Limited
Biotechnology
TLX AU)
Patrick Soon-Shiong, Chairman Pharmaceuticals
& CEO
Christian Behrenbruch, CEO
Quotient Limited (QTNT) MedTech Chris Lindop, CFO
Swedish Orphan Biovitrum AB (SOBI SS) Biotechnology Henrik Stenqvist; CFO; Armin Reininger; Head of Medical & Scientific Affairs
QIAGEN N.V. (QGEN)** FC Life Sciences Peer Schatz, CEO
Medpace Holdings, Inc. (MEDP)** FC Healthcare Services August Troendle, President & CEO; Jesse Geiger, CFO & COO, Laboratory Operations
Heska Corporation (HSKA)** NantKwest, Inc. (NK)
Pandion Therapeutics, Inc.
Animal Health
Biotechnology
(Private)
Kevin Wilson, CEO & President Patrick Soon-Shiong, Chairman Biotechnology
& CEO
Anthony Coyle, President &
CEO
Surgery Partners, Inc. (SGRY) NovoCure Limited (NVCR)
FC
MedTech
Healthcare Services
Bill Doyle, Executive Chairman
Tom Cowhey, CFO
Lonza Group Ltd (LONN VX) Biotechnology Rodolfo Savitzky, CFO
Urogen Pharma Ltd. (URGN) Biotechnology Liz Barrett, CEO
miRagen Therapeutics, Inc. (MGEN) Biotechnology William Marshall, President & CEO
Lyra Therapeutics (Private)** Arcutis, Inc. (Private)
Biotechnology
Pharmaceuticals
Maria Palasis, President & CEO Frank Watanabe, President &
CEO
Knight Therapeutics Inc. (04K GR) Pharmaceuticals Jonathan Goodman, CEO
Allogene Therapeutics, Inc. (ALLO) Biotechnology Eric Schmidt, CFO
Cerner Corporation (CERN) HCIT Marc Naughton, EVP & CFO
Mithra Women's Health (MITRA BB) Pharmaceuticals Alexandra Deschner, IR Officer
Eagle Pharmaceuticals, Inc. (EGRX) Pharmaceuticals Scott Tarriff, CEO; Pete Meyers, CFO
Scholar Rock, Inc. (SRRK) Pharmaceuticals Nagesh Mahanthappa, President & CEO
Intuity Medical, Inc. (Private) MedTech Emory Anderson, President & CEO
Addus HomeCare Corporation (ADUS) FC Healthcare Services Dirk Allison, President & CEO; Brian Poff, EVP & CFO
PRA Health Sciences, Inc. (PRAH)** FC Healthcare Services Colin Shannon, CEO; Mike Bonello, CFO
Bio-Rad Laboratories (BIO) Life Sciences Norman Schwartz, President; Ilan Daskal, CFO
Pacira BioSciences, Inc. (PCRX)** Pharmaceuticals Dave Stack, CEO
Translate Bio, Inc. (TBIO) Biotechnology Ronald Renaud, CEO
Nordic Nanovector ASA (NANO NO) Biotechnology Eduardo Bravo, CEO
Cadent Therapeutics (Private) Pharmaceuticals Jodie Morrison, CEO
Viking Therapeutics, Inc. (VKTX) Biotechnology
Brian Lian, President & CEO
Teladoc Health (TDOC) Healthcare Services Jason Gorevic, CEO; Valerie Haertel, IR
H. Lundbeck A/S (LUN DC) Pharmaceuticals Peter Anastasiou, EVP, Lundbeck North America
Retrophin, Inc. (RTRX)** FC Biotechnology Eric Dube, CEO
Surmodics, Inc. (SRDX) MedTech Gary Maharaj, President & CEO; Tim Arens, VP of Finance & CFO
CytomX Therapeutics, Inc. Indivior PLC (INDV LN)
(CTMX)
Pharmaceuticals
Biotechnology
Shaun Thaxter, CEO
Sean McCarthy, President, CEO
& Chairman
Vanda Pharmaceuticals Inc. LivaNova PLC (LIVN) FC
(VNDA)
MedTech
Biotechnology
Damien McDonald, CEO
Mihales Polymeropoulos, M.D.,
President & CEO; Jim Kelly,
EVP, CFO & Treasurer
Humana Inc. (HUM) FC Healthcare Services Bruce Broussard, President & CEO; Brian Kane, CFO
Acadia Healthcare Company, Inc. (ACHC)** FC Healthcare Services Debbie Osteen, CEO; David Duckworth, CFO
OptiNose, Inc. (OPTN) Pharmaceuticals Peter Miller, CEO
Dova Pharmaceuticals, Inc. (DOVA) Pharmaceuticals David Zaccardelli, CEO
KSQ Therapeutics, Inc. (Private) Biotechnology David P. Meeker Meeker, CEO
CRISPR Therapeutics AG (CRSP) Biotechnology Sam Kulkarni, CEO
bluebird bio, Inc. (BLUE) Biotechnology Chip Baird, CFO
Roche Holding AG (ROG VX) Pharmaceuticals Alan Hippe, CFO Roche
HMS Holdings Corp. (HMSY)** Healthcare Services Jeff Sherman, EVP & CFO
Establishment Labs Holdings Urovant Sciences Ltd. (UROV) Grace Therapeutics Inc.
Inc. (ESTA)
Pharmaceuticals
(Private)
MedTech
Keith Katkin, President & CEO; Biotechnology
Juan Jose Chacon Quiros, CEO; Cornelia Haag-Molkenteller, George Kottayil, CEO; Bruce
Renee Gaeta, CFO
CMO; Michael McFadden,
Hochstadt, COO
Chief Commercial Officer; Paul
Mudd, VP, Clinical Research
** No Breakout FC Fireside Chat
AGENDA TUESDAY, JUNE 4, 2019
Jefferies 2019 Global Healthcare Conference
12:00 PM 12:15 PM
BALLROOM 1 BREAKOUT: URIS
BALLROOM 2 BREAKOUT: JUILLIARD
Break for Lunch / Presentation Room Setup
BALLROOM 3 BREAKOUT: BROADWAY
BALLROOM 4 BREAKOUT: CARNEGIE
BALLROOM 5 BREAKOUT: ALVIN
"Drug Pricing: The Politics and Outlook" Ted Kennedy, Jr., Partner, Epstein Becker Green & Lynn Shapiro Snyder, Senior Member, Epstein Becker Green
MOROSCO BREAKOUT: PLYMOUTH
IMPERIAL BREAKOUT: BOOTH
1:30 PM 2:00 PM 2:30 PM 3:00 PM 3:30 PM 4:00 PM 4:30 PM
Fluidigm Corporation (FLDM) Life Sciences Vikram Jog, CFO
United Therapeutics Corporation (UTHR) Biotechnology James Edgemond, CFO & Treasurer
Novartis AG (NOVN VX)** FC Amedisys, Inc. (AMED) FC
Pharmaceuticals
Healthcare Services
Fabrice Chouraqui, US
Paul Kusserow, CEO
President
Xeris Pharmaceuticals, Inc. (XERS)** Pharmaceuticals Paul Edick, CEO
IGM Biosciences, Inc. (Private) Biotechnology Fred M. Schwarzer, CEO
BioScrip, Inc. (BIOS) Healthcare Services Dan Greenleaf, President & CEO; Steve Deitsch, SVP, CFO & Treasurer
NextGen Healthcare, Inc. (NXGN) HCIT Rusty Frantz, President & CEO
The Cooper Companies, Inc. (COO) FC MedTech Brian Andrews, SVP, CFO & Treasurer
Veloxis Pharmaceuticals A/S (VELO DC) Pharmaceuticals Craig Collard, CEO
Bellicum Pharmaceuticals, Inc. (BLCM)** Biotechnology Rick Fair, President & CEO
Veru Inc. (VERU) Pharmaceuticals Mitchell Steiner, Chairman, President CEO
Aura Biosciences, Inc. (Private) Biotechnology Elisabet de los Pinos, CEO
Ra Pharmaceuticals, Inc. (RARX) Biotechnology Doug Treco, President & CEO
MEDNAX, Inc. (MD) FC Healthcare Services Stephen Farber, CFO; Charles Lynch, VP, Strategy
Mettler-Toledo International Inc. (MTD) FC Life Sciences Shawn Vadala, CFO
Aerie Pharmaceuticals, Inc. (AERI)** Pharmaceuticals
Vince Anido, Chairman & CEO
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Pharmaceuticals Yuval Cohen, CEO
Collegium Pharmaceutical, Inc. (COLL) Pharmaceuticals Joe Ciaffoni, CEO; Paul Brannelly, EVP & CFO
Catalyst Biosciences, Inc. (CBIO) Biotechnology Nassim Usman, President & CEO; Fletcher Payne, CFO; Howard Levy, CMO
BioArctic AB (BIOAB LN) Biotechnology Gunilla Osswald, CEO; Johanna F?lting, VP, Translational Science & Pharmacology
West Pharmaceutical Services, Inc. (WST)** FC MedTech Eric Green, CEO & President
Hologic Inc. (HOLX) MedTech Karleen Oberton, CFO; Michael Watts, VP, IR & Corp Communications
Vocera Communications, Inc. Akebia Therapeutics, Inc.
(VCRA) FC
(AKBA)**
HCIT
Biotechnology
Brent Lang, CEO; Sue Dooley, John Butler, CEO
Head of IR
Verrica Pharmaceuticals Inc. (VRCA) Pharmaceuticals Ted White, President & CEO
Minerva Neurosciences, Inc. (NERV) Biotechnology Remy Luthringer, Executive Chairman & CEO
Corcept Therapeutics Incorporated (CORT) Pharmaceuticals Joseph Belanoff, CEO
Galapagos NV (GLPG NA) Biotechnology Onno van de Stolpe, CEO
Exact Sciences Corporation (EXAS) FC Life Sciences Kevin Conroy, President & CEO
Apellis Pharmaceuticals, Inc. (APLS) Biotechnology Cedric Francois, CEO
Banca Farmafactoring S.p.a. (BFF IM) Healthcare Services Massimiliano Belingheri, CEO; Emanuele Bona, CFO; Enrico Tadiotto, Head of IR, Strategy, M&A
PDL BioPharma, Inc. (PDLI) Pharmaceuticals Dominique Monnet, President & CEO; Peter Garcia, CFO
EUSA Pharma Ltd (Private) Pharmaceuticals Lee Morley, CEO
Arcus Biosciences, Inc. (RCUS)** Biotechnology Terry Rosen, CEO; Katherine Bock, VP, IR & Corp Strategy
Luminex Corporation
Aurora Cannabis Inc.
(LMNX) FC
(ACB)
Life Sciences
Cannabis
Homi Shamir, President & CEO Cam Battley, Chief Corporate
Officer
Dicerna Pharmaceuticals, Inc. (DRNA) Biotechnology Doug Fambrough, CEO
BioDelivery Sciences International, Inc. (BDSI) Pharmaceuticals Herm Cukier, CEO
Kiadis Pharma N.V. (KDS NA)** Biotechnology Arthur Lahr, CEO
Metacrine, Inc. (Private)** Biotechnology Ken Song, CEO
Orasure Technologies, Inc. (OSUR) FC Life Sciences Stephen Tang, President & CEO; Roberto Cuca, CFO
HEXO Corp. (HEXO B3) Cannabis Sebastien St-Louis, CEO & Co-Founder
Abiomed Inc (ABMD) MedTech Michael Minogue, CEO; Todd Trapp, CFO
R1 RCM Inc. (RCM)** FC
Camurus (CAMX SS)**
Healthcare Services
Pharmaceuticals
Joe Flanagan, President & CEO; Fredrik Tiberg, President &
Chris Ricaurte, CFO &
CEO
Treasurer
Marker Therapeutics, Inc. (MRKR) Biotechnology Peter Hoang, President & CEO
Compugen Ltd. (CGEN)** Biotechnology Anat Cohen-Dayag, President & CEO
** No Breakout FC Fireside Chat
AGENDA WEDNESDAY, JUNE 5, 2019
Jefferies 2019 Global Healthcare Conference
7:30 AM 8:00 AM
8:30 AM 9:00 AM 9:30 AM
10:00 AM
10:30 AM 11:00 AM 11:30 AM
BALLROOM 1 BREAKOUT: URIS
Breakfast & Registration
BALLROOM 2 BREAKOUT: JUILLIARD
BALLROOM 3 BREAKOUT: BROADWAY
BALLROOM 4 BREAKOUT: CARNEGIE
BALLROOM 5 BREAKOUT: ALVIN
MOROSCO BREAKOUT: PLYMOUTH
IMPERIAL BREAKOUT: BOOTH
Acorda Therapeutics, Inc. (ACOR)** FC Biotechnology Ron Cohen, M.D., President & CEO
MorphoSys AG (MOR GR) Biotechnology Jens Holstein, CFO
Alcon, Inc. (ALC)** FC Healthcare Services David Endicott, CEO; Tim Stonesifer, CFO; Christina Cheng, Global Head, IR
Intra-Cellular Therapies, Inc. (ITCI)** Biotechnology Sharon Mates, CEO
Castlight Health, Inc. (CSLT) HCIT Siobhan Nolan Mangini, CFO
Sierra Oncology, Inc. (SRRA Biotechnology Dr. Nick Glover, President & CEO
Aileron Therapeutics, Inc. (ALRN) Biotechnology Manuel Aivado, President & CEO; Donald Dougherty, SVP & CFO
Amphastar Pharmaceuticals, Inc. (AMPH) Pharmaceuticals Jason Shandell, President; Bill Peters, CFO
Esperion (ESPR) FC Pharmaceuticals Jason Shandell, President; Tim Mayleben, President & CEO
Charles River Laboratories International, Inc. (CRL) FC Healthcare Services David Smith, EVP & CFO
Atara Biotherapeutics, Inc. (ATRA) Biotechnology Utpal Koppikar, CFO
Genfit SA (GNFT) Life Sciences Dean Hum, COO
Aeglea BioTherapeutics, Inc. (AGLE) Biotechnology Anthony Quinn, CEO
Verona Pharma plc (VRNA) Biotechnology Jan-Anders Karlsson, CEO; Piers Morgan, CFO
TG Therapeutics, Inc. (TGTX) Brooks Automation, Inc.
Biotechnology
(BRKS)
Michael Weiss, CEO
Life Sciences
Lindon Robertson, EVP & CFO
Array BioPharma Inc. (ARRY)** FC Biotechnology Ron Squarer, CEO
CareDx, Inc (CDNA) Biotechnology Peter Maag, CEO
Synthorx, Inc. (THOR) Biotechnology Marcos Milla, Chief Scientific Officer
Assembly Biosciences, Inc. (ASMB)** Biotechnology Derek Small, President & CEO
Enzyvant (Private) Pharmaceuticals Rachelle Jacques, CEO
Cara Therapeutics, Inc. (CARA) Biotechnology Derek Chalmers, CEO
Bio-Techne Corporation (TECH) Life Sciences Chuck Kummeth, CEO
ICON Plc (ICLR) FC Healthcare Services Steve Cutler, CEO
U.S. Physical Therapy, Inc. (USPH) FC Healthcare Services Christopher Reading, CEO
Kezar Life Sciences, Inc.
Oncorus, Inc. (Private)
(KZR) FC
Biotechnology
Biotechnology
Ted Ashburn, CEO
John Fowler, CEO; Christopher
Kirk, President & CSO; Niti
Goel, CMO
Beam Therapeutics Inc. (Private) Biotechnology John Evans, CEO
Rubius Therapeutics, Inc. (RUBY) Biotechnology Pablo Cagnoni, CEO
BioCryst Pharmaceuticals, Inc. (BCRX) FC Biotechnology Jon Stonehouse, CEO
OSI Systems, Inc. (OSIS) MedTech Alan Edrick, EVP & CFO
Syneos Health, Inc. (SYNH) Healthcare Services Alistair Macdonald, CEO
Trends in Healthcare Private Equity Panel Moderator: Michael Dodds Panelists: Andrew Kaplan, Bain Robert Reistetter, Quad-C John Richardson, Cinven TJ Rose, ABRY
Coherus Biosciences, Inc. (CHRS)** FC Biotechnology Denny Lanfear, President & CEO
Cosmo Pharmaceuticals N.V. (COPN SW) Pharmaceuticals Alessandro Della Cha, CEO
Kiniksa Pharmaceuticals, Ltd. Affimed N.V. (AFMD)
(KNSA)
Biotechnology
Biotechnology
Adi Hoess, CEO
Sanj K. Patel, CEO & Chairman
of the Board; John Paolini,
CMO
Equillium, Inc. (EQ) Biotechnology Daniel Bradbury, Chairman & CEO
TCR2 Therapeutics Inc. (TCRR) Biotechnology Ian Somaiya, CFO
Concert Pharmaceuticals, Inc. Poxel SA (POXEL FP)
(CNCE)
Biotechnology
Biotechnology
Thomas Kuhn, CEO
Roger Tung, President & CEO
Constellation Pharmaceuticals, Inc. (CNST) Biotechnology Jigar Raythatha, CEO
Chemed Corporation (CHE)** FC Healthcare Services Kevin McNamara, President & CEO
Medtronic plc (MDT) FC MedTech Mike Coyle, EVP & President, Cardiac & Vascular Group
Replimune Group, Inc. (REPL) Biotechnology Philip Astley-Sparkle, Executive Chairman & Director
Iovance Biotherapeutics, Inc. (IOVA) Biotechnology Maria Fardis, President & CEO; Timothy Morris, CFO
Gilead Sciences, Inc. (GILD)** FC Biotechnology Daniel O'Day, Chairman & CEO
Immunomedics, Inc. (IMMU)** FC Biotechnology Behzad Aghazadeh, Executive Chairman
Xenon Pharmaceuticals Inc. (XENE)** Biotechnology Simon Pimstone, CEO
PureTech Health plc (PRTC Kadmon Holdings, Inc.
LN)
(KDMN)**
Biotechnology
Biotechnology
Daphne Zohar, Founder & CEO Harlan Waksal, President &
CEO
Corvus Pharmaceuticals, Inc. BlueRock Therapeutics
(CRVS)
(Private)
Biotechnology
Biotechnology
Richard Miller, President & CEO Emile Nuwaysir, CEO
Orexo AB (ORX SS) Pharmaceuticals Joseph DeFeo, EVP & CFO; Robert DeLuca, President Orexo US Inc
Intec Pharma Ltd. (NTEC)** Biotechnology Jeffrey Meckler, Vice Chairman & CEO
** No Breakout FC Fireside Chat
AGENDA WEDNESDAY, JUNE 5, 2019
Jefferies 2019 Global Healthcare Conference
12:00 PM 12:15 PM
1:00 PM 2:00 PM
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
BALLROOM 1 BREAKOUT: URIS
BALLROOM 2 BREAKOUT: JUILLIARD
Break for Lunch / Presentation Room Setup
BALLROOM 3 BREAKOUT: BROADWAY
BALLROOM 4 BREAKOUT: CARNEGIE
BALLROOM 5 BREAKOUT: ALVIN
MOROSCO BREAKOUT: PLYMOUTH
IMPERIAL BREAKOUT: BOOTH
Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center ~ Michael Yee, Managing Director, Equity Research, Jefferies (12:15-12:45pm)
Michael R. Bloomberg, Founder, Bloomberg LP and Bloomberg Philanthropies & 108th Mayor of the City of New York ~ Moderated by Brian Friedman, President, Jefferies Financial Group (1:00-1:45pm)
WAVE Life Sciences Ltd. (WVE) Biotechnology Paul Bolno, President & CEO
Genomic Health, Inc. (GHDX) Reata Pharmaceuticals, Inc.
Life Sciences
(RETA) FC
Kim Popovits, CEO; Brad Cole, Biotechnology
CFO; Emily Faucette, VP, IR
Colin Meyer, Chief Medical
Officer; Vinny Jindal, VP,
Strategy
Supernus Pharmaceuticals, Inc. (SUPN) FC Pharmaceuticals Jack Khattar, CEO
Odonate Therapeutics, Inc. (ODT) Pharmaceuticals Kevin Tang, CEO
GlycoMimetics, Inc. (GLYC) Biotechnology Rachel King, CEO
Passage BIO, Inc. (Private)** Life Sciences Jill Quigley, COO & General Counsel
Rigel Pharmaceuticals, Inc.)** Biotechnology Dean Schorno, CFO
UDG Healthcare plc (UDG LN) Healthcare Services Liam Logue, Head of Corp Development
Align Technology Inc. (ALGN) MedTech John Morici, CFO
Autolus Therapeutics plc (AUTL)** FC Biotechnology Christian Itin, CEO
Abeona Therapeutics Inc. (ABEO) Biotechnology Jo?o Siffert, CEO, CMO & Head of R&D
Seres Therapeutics, Inc. (MCRB) Biotechnology Eric Shaff, President & CEO
Yumanity Therapeutics Inc. (Private) Biotechnology Tony Coles, CEO
Stealth BioTherapeutics Incorporated (MITO) Pharmaceuticals Reenie McCarthy, CEO
Epizyme, Inc. (EPZM) Biotechnology Robert Bazemore, President & CEO
Heron Therapeutics, Inc. (HRTX) Biotechnology Barry Quart, President & CEO
AxoGen, Inc. (AXGN) MedTech Karen Zaderej, Chairman, President & CEO
Karyopharm Therapeutics Inc. (KPTI) Biotechnology Michael Kauffman, CEO
AMAG Pharmaceuticals, Inc. (AMAG) Pharmaceuticals Bill Heiden, CEO
Arbutus Biopharma Corporation (ABUS) Biotechnology Michael McElhaugh, Chief Business Officer
Cassiopea S.p.A. (SKIN SW) Pharmaceuticals Diana Harbort, CEO
Orion Corporation (ORNBV FH) Pharmaceuticals Jari Karlson, CFO
Canopy Growth Corporation Spectrum Pharmaceuticals,
(CGC)
Inc. (SPPI)
Cannabis
Biotechnology
Bruce Linton, Chairman & CEO Joe Turgeon, CEO & President
Aclaris Therapeutics, Inc. (ACRS) Biotechnology Neal Walker, President & CEO; Stuart Shanler, CSO; Mike Tung, SVP, IR
BELLUS Health Inc. (BLU CN) Biotechnology Roberto Bellini, President & CEO
EyePoint Pharmaceuticals, Inc. (EYPT) Biotechnology Nancy Lurker, President & CEO
Allscripts Healthcare Solutions, Inc. (MDRX)** HCIT Dennis Olis, CFO
Blueprint Medicines Corporation (BPMC) Biotechnology Kate Haviland, COO
LHC Group, Inc. (LHCG) FC Zai Lab Limited (ZLAB)
Healthcare Services
Biotechnology
Keith Myers, Chairman & CEO; Tao Fu, President & COO
Josh Proffitt, CFO; Bruce
Greenstein, Chief Strategy
Officer
Tabula Rasa HealthCare, Inc. (TRHC) Healthcare Services Brian Adams, CFO
Hanger, Inc. (HNGR) Healthcare Services Thomas Kiraly, CFO; Seth Frank, VP, Treasury & IR
ALX Oncology (Private) Biotechnology Jaume Pons, CEO
Evolus, Inc. (EOLS)** Pharmaceuticals David Moatazedi, President & CEO; Lauren Silvernail, CFO & EVP, Corp Development
Healthcare Services Group, Inc. (HCSG) Healthcare Services Ted Wahl, President & CEO; Matt McKee, Chief Communications Officer
Integra LifeSciences Holdings Brookdale Senior Living Inc.
Corporation (IART)** FC
(BKD) FC
MedTech
Healthcare Services
Peter Arduini, President & CEO Cindy Baier, CEO
Cytosorbents Corporation (CTSO) MedTech Phillip Chan, CEO & President
CTI BioPharma Corp. (CTIC) Biotechnology Bruce Seeley, COO
Cardiva Medical, Inc. (Private) MedTech John Russell, CEO
** No Breakout FC Fireside Chat
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.